Next Article in Journal
Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model
Previous Article in Journal
An Initial Indonesian Genome-Wide SNP-Array Study with Functional Variant Prioritization Reveals NASP and GPR78 Candidate SNVs in Hepatocellular Carcinoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242

1
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 22252, Saudi Arabia
2
Saudi Diabetes Research Group, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 22252, Saudi Arabia
3
Food, Nutrition, and Lifestyle Research Unit, King Fahd for Medical Research Center, King Abdulaziz University, Jeddah 22252, Saudi Arabia
4
Department of Food and Nutrition, Faculty of Human Sciences and Design, King Abdulaziz University, Jeddah 22252, Saudi Arabia
5
Department of Family Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 22252, Saudi Arabia
6
Department of Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 22252, Saudi Arabia
7
Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
8
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Alexandria University, Alexandria 21561, Egypt
9
King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah 22384, Saudi Arabia
10
Department of Public Health, University of Helsinki, FI-00014 Helsinki, Finland
11
Public Health Promotion Unit, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland
*
Author to whom correspondence should be addressed.
Biomedicines 2026, 14(4), 932; https://doi.org/10.3390/biomedicines14040932
Submission received: 15 April 2026 / Accepted: 15 April 2026 / Published: 20 April 2026
(This article belongs to the Section Endocrinology and Metabolism Research)

Error in Table

In the original publication [1], there was a mistake in “Table 2. Prevalence of MetS and its components in different sex groups in people <32 years and 32+ years of age” as published. The standard deviation of the diastolic blood pressure (DBP) of the subgroup “Normal BP” in women 32+ years of age should be reported as “8.3” instead of “0.8”. The corrected “Table 2. Prevalence of MetS and its components in different sex groups in people <32 years and 32+ years of age” appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Eldakhakhny, B.; Enani, S.; Jambi, H.; Ajabnoor, G.; Al-Ahmadi, J.; Al-Raddadi, R.; Alsheikh, L.; Abdulaal, W.H.; Gad, H.; Borai, A.; et al. Prevalence and Factors Associated with Metabolic Syndrome among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242. [Google Scholar] [CrossRef] [PubMed]
Table 2. Prevalence of MetS and its components in different sex groups in people <32 years and 32+ years of age.
Table 2. Prevalence of MetS and its components in different sex groups in people <32 years and 32+ years of age.
Age < 32Age 32+
Men
n = 471
Women
n = 307
p-Value bMen
n = 289
Women
n = 272
p-Value b
n (%)Mean ± SDn (%)Mean ± SD n (%)Mean ± SDn (%)Mean ± SD
WC ^
Normal WC369 (78.3)87.4 ± 9.4225 (73.3)75.2 ± 7.4<0.001156 (54.2)92.7 ± 7.577 (28.4)78.7 ± 7.8<0.001
Elevated WC102 (21.7)115.8 ± 12.182 (26.7)100 ± 10.2<0.001132 (45.8)115 ± 10194 (71.6)103 ± 12<0.001
p-value a0.105 <0.001
BP ^
Normal BP338 (71.8)SBP: 115.1 ± 8.3261 (85)SBP: 107 ± 10<0.001169 (58.5)SBP: 116 ± 7192 (70.6)SBP: 109 ± 10<0.001
DBP: 69.8 ± 9.2 DBP: 66.4 ± 8.4<0.001 DBP: 72.9 ± 8 DBP: 67.4 ± 8.3<0.001
Elevated BP133 (28.2)SBP: 131.2 ± 11.346 (15)SBP: 127 ± 150.061120 (41.5)SBP: 136 ± 1780 (29.4)SBP: 134 ± 190.461
DBP: 82.8 ± 11.3 DBP: 86.2 ± 9.60.054 DBP: 85 ± 10.4 DBP: 83.8 ± 11.80.462
p-value a<0.001 0.003
HDL-C ^
Normal HDL-C420 (89.4)1.3 ± 0.2235 (76.5)1.6 ± 0.2<0.001223 (77.2)1.3 ± 0.2184 (67.6)1.6 ± 0.2<0.001
Low HDL-C50 (10.6)0.9 ± 0.172 (23.5)1.1 ± 0.2<0.00166 (22.8)1 ± 0.288 (32.4)1.2 ± 0.2<0.001
p-value a<0.001 0.012
TG ^
Normal TG389 (82.8)0.94 ± 0.32288 (93.8)0.79 ± 0.27<0.001162 (56.1)1.1 ± 0.33203 (74.6)1 ± 0.330.007
High TG81 (17.2)2.66 ± 1.2419 (6.2)1.98 ± 0.730.024127 (43.9)2.68 ± 1.0469 (25.4)2.03 ± 0.88<0.001
p-value a<0.001 <0.001
FPG ^
Normal FPG427 (90.7)4.2 ± 0.5282 (91.9)4.1 ± 0.50.82198 (68.5)4.4 ± 0.6202 (74.3)4.3 ± 0.60.097
High FPG44 (9.3)5.1 ± 1.325 (8.1)5 ± 0.90.59891 (31.5)6 ± 2.770 (25.7)5.4 ± 2.10.16
p-value a0.565 0.132
MetS ^
No MetS436 (92.6) 293 (95.4) 206 (71.3) 192 (70.6)
MetS35 (7.4) 14 (4.6) 83 (28.7) 80 (29.4)
p-value a0.107 0.857
a p-value was obtained to compare the proportions between the two sex groups in each age group using the chi-square test. b p-value was obtained to compare the means of the two groups of people with MetS and without MetS using an independent t-test. ^ all components were significantly more prevalent in 32+ years adults compared with <32 years in both sex groups (p < 0.001 for all components except for low HDL in woman p = 0.014). Statistically significant p-values are shown in bold font.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Eldakhakhny, B.; Enani, S.; Jambi, H.; Ajabnoor, G.; Al-Ahmadi, J.; Al-Raddadi, R.; Alsheikh, L.; Abdulaal, W.H.; Gad, H.; Borai, A.; et al. Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242. Biomedicines 2026, 14, 932. https://doi.org/10.3390/biomedicines14040932

AMA Style

Eldakhakhny B, Enani S, Jambi H, Ajabnoor G, Al-Ahmadi J, Al-Raddadi R, Alsheikh L, Abdulaal WH, Gad H, Borai A, et al. Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242. Biomedicines. 2026; 14(4):932. https://doi.org/10.3390/biomedicines14040932

Chicago/Turabian Style

Eldakhakhny, Basmah, Sumia Enani, Hanan Jambi, Ghada Ajabnoor, Jawaher Al-Ahmadi, Rajaa Al-Raddadi, Lubna Alsheikh, Wesam H. Abdulaal, Hoda Gad, Anwar Borai, and et al. 2026. "Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242" Biomedicines 14, no. 4: 932. https://doi.org/10.3390/biomedicines14040932

APA Style

Eldakhakhny, B., Enani, S., Jambi, H., Ajabnoor, G., Al-Ahmadi, J., Al-Raddadi, R., Alsheikh, L., Abdulaal, W. H., Gad, H., Borai, A., Bahijri, S., & Tuomilehto, J. (2026). Correction: Eldakhakhny et al. Prevalence and Factors Associated with Metabolic Syndrome Among Non-Diabetic Saudi Adults: A Cross-Sectional Study. Biomedicines 2023, 11, 3242. Biomedicines, 14(4), 932. https://doi.org/10.3390/biomedicines14040932

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop